Prohost Letter #387

Prohost Letter #387
Topic of the Week
Which Firms Will Get It Right – Deleting DMD Children’s Despair?

The topic is important because, first and foremost, Duchenne muscular dystrophy (DMD) disables children. Also because, from no treatment at all, now we have several biotech firms developing various drugs based on different scientific strategies. The new approaches have increased in number and have increased the competition between various DMD treatments, which went form nonexistent to existent, to getting spicy, then spicier . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.